MK-2894
MK-2894 is a potent, selective, orally active and high affinity (Ki=0.56 nM) full antagonist against E prostanoid receptor 4 (EP4 receptor) (IC50=2.5 nM) . MK-2894 possesses potent anti-inflammatory activity in animal models of pain/inflammation and can be used for the research of arthritis[1][2].
Product Specifications
CAS Number
1006036-87-8
UNSPSC
12352005
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Endocrinology
Assay Protocol
https://www.medchemexpress.com/MK-2894.html
Concentration
10mM
Purity
99.31
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(O)C1=CC=C(C2(NC(C3=C(C)SC(C)=C3CC4=CC=C(C(F)(F)F)C=C4)=O)CC2)C=C1
Molecular Formula
C25H22F3NO3S
Molecular Weight
473.51
References & Citations
[1]Blouin M, et al. The discovery of 4-{1-[ ({2,5-dimethyl-4-[4- (trifluoromethyl) benzyl]-3-thienyl}carbonyl) amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist. J Med Chem. 2010 Mar 11;53 (5) :2227-38.|[2]Tijana Markovič, et al. Structural features of subtype-selective EP receptor modulators. Drug Discov Today. 2017 Jan;22 (1) :57-71.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EP
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041266-100 1x 100 µL
Cytokeratin 8 (KRT8) (B22.1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
